These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 21134749

  • 41. Synthesis and biological evaluation of benzoisothiazole derivatives possessing N,N-dimethylformimidamide group as 5-HT₆ receptor antagonists.
    Yoo E, Hayat F, Rhim H, Park Choo HY.
    Bioorg Med Chem; 2012 Apr 15; 20(8):2707-12. PubMed ID: 22405919
    [Abstract] [Full Text] [Related]

  • 42. Synthesis and SAR of (piperazin-1-yl-phenyl)-arylsulfonamides: a novel series of atypical antipsychotic agents.
    Park CM, Kim SY, Park WK, Choi JH, Seong CM.
    Bioorg Med Chem Lett; 2010 Sep 01; 20(17):5221-4. PubMed ID: 20655748
    [Abstract] [Full Text] [Related]

  • 43. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y, Fujiwara I, Suzuki K, Harada H, Yoshikawa T, Yoshida N, Kato S.
    J Med Chem; 2003 Feb 27; 46(5):702-15. PubMed ID: 12593651
    [Abstract] [Full Text] [Related]

  • 44. Arene- and quinoline-sulfonamides as novel 5-HT7 receptor ligands.
    Zajdel P, Marciniec K, Maślankiewicz A, Paluchowska MH, Satała G, Partyka A, Jastrzębska-Więsek M, Wróbel D, Wesołowska A, Duszyńska B, Bojarski AJ, Pawłowski M.
    Bioorg Med Chem; 2011 Nov 15; 19(22):6750-9. PubMed ID: 22001327
    [Abstract] [Full Text] [Related]

  • 45. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
    Cappelli A, Anzini M, Vomero S, Mennuni L, Makovec F, Doucet E, Hamon M, Bruni G, Romeo MR, Menziani MC, De Benedetti PG, Langer T.
    J Med Chem; 1998 Feb 26; 41(5):728-41. PubMed ID: 9513601
    [Abstract] [Full Text] [Related]

  • 46. 5-Cyclic amine-3-arylsulfonylindazoles as novel 5-HT6 receptor antagonists.
    Haydar SN, Yun H, Andrae PM, Mattes J, Zhang J, Kramer A, Smith DL, Huselton C, Graf R, Aschmies S, Schechter LE, Comery TA, Robichaud AJ.
    J Med Chem; 2010 Mar 25; 53(6):2521-7. PubMed ID: 20170099
    [Abstract] [Full Text] [Related]

  • 47. Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands.
    Zhuang ZP, Kung MP, Mu M, Kung HF.
    J Med Chem; 1998 Jan 15; 41(2):157-66. PubMed ID: 9457239
    [Abstract] [Full Text] [Related]

  • 48. Discovery of an orally efficacious inhibitor of coagulation factor Xa which incorporates a neutral P1 ligand.
    Choi-Sledeski YM, Kearney R, Poli G, Pauls H, Gardner C, Gong Y, Becker M, Davis R, Spada A, Liang G, Chu V, Brown K, Collussi D, Leadley R, Rebello S, Moxey P, Morgan S, Bentley R, Kasiewski C, Maignan S, Guilloteau JP, Mikol V.
    J Med Chem; 2003 Feb 27; 46(5):681-4. PubMed ID: 12593648
    [Abstract] [Full Text] [Related]

  • 49. Extended N-Arylsulfonylindoles as 5-HT₆ Receptor Antagonists: Design, Synthesis & Biological Evaluation.
    Vera G, Lagos CF, Almendras S, Hebel D, Flores F, Valle-Corvalán G, Pessoa-Mahana CD, Mella-Raipán J, Montecinos R, Recabarren-Gajardo G.
    Molecules; 2016 Aug 16; 21(8):. PubMed ID: 27537868
    [Abstract] [Full Text] [Related]

  • 50. Effect of several 5-hydroxytryptamine(1A) receptor ligands on the micturition reflex in rats: comparison with WAY 100635.
    Testa R, Guarneri L, Poggesi E, Angelico P, Velasco C, Ibba M, Cilia A, Motta G, Riva C, Leonardi A.
    J Pharmacol Exp Ther; 1999 Sep 16; 290(3):1258-69. PubMed ID: 10454502
    [Abstract] [Full Text] [Related]

  • 51. Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134).
    Bromidge SM, Clarke SE, Gager T, Griffith K, Jeffrey P, Jennings AJ, Joiner GF, King FD, Lovell PJ, Moss SF, Newman H, Riley G, Rogers D, Routledge C, Serafinowska H, Smith DR.
    Bioorg Med Chem Lett; 2001 Jan 08; 11(1):55-8. PubMed ID: 11140733
    [Abstract] [Full Text] [Related]

  • 52. Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylamines.
    Mewshaw RE, Zhou D, Zhou P, Shi X, Hornby G, Spangler T, Scerni R, Smith D, Schechter LE, Andree TH.
    J Med Chem; 2004 Jul 15; 47(15):3823-42. PubMed ID: 15239661
    [Abstract] [Full Text] [Related]

  • 53. Synthesis and biological evaluation of (phenylpiperazinyl-propyl)arylsulfonamides as selective 5-HT(2A) receptor antagonists.
    Yoo E, Yoon J, Pae AN, Rhim H, Park WK, Kong JY, Park Choo HY.
    Bioorg Med Chem; 2010 Feb 15; 18(4):1665-75. PubMed ID: 20096593
    [Abstract] [Full Text] [Related]

  • 54. Aryl biphenyl-3-ylmethylpiperazines as 5-HT7 receptor antagonists.
    Kim J, Kim Y, Tae J, Yeom M, Moon B, Huang XP, Roth BL, Lee K, Rhim H, Choo IH, Chong Y, Keum G, Nam G, Choo H.
    ChemMedChem; 2013 Nov 15; 8(11):1855-64. PubMed ID: 24039134
    [Abstract] [Full Text] [Related]

  • 55. Development of molecular probes for the human 5-HT(6) receptor.
    Vázquez-Villa H, González-Vera JA, Benhamú B, Viso A, Fernández de la Pradilla R, Junquera E, Aicart E, López-Rodríguez ML, Ortega-Gutiérrez S.
    J Med Chem; 2010 Oct 14; 53(19):7095-106. PubMed ID: 20845907
    [Abstract] [Full Text] [Related]

  • 56. Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR.
    Intagliata S, Modica MN, Pittalà V, Salerno L, Siracusa MA, Cagnotto A, Salmona M, Romeo G.
    Bioorg Med Chem Lett; 2016 Aug 15; 26(16):4052-6. PubMed ID: 27396505
    [Abstract] [Full Text] [Related]

  • 57. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
    López-Rodríguez ML, Morcillo MJ, Fernández E, Rosado ML, Pardo L, Schaper K.
    J Med Chem; 2001 Jan 18; 44(2):198-207. PubMed ID: 11170629
    [Abstract] [Full Text] [Related]

  • 58. 1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors.
    Sorbi C, Franchini S, Tait A, Prandi A, Gallesi R, Angeli P, Marucci G, Pirona L, Poggesi E, Brasili L.
    ChemMedChem; 2009 Mar 18; 4(3):393-9. PubMed ID: 19152363
    [Abstract] [Full Text] [Related]

  • 59. The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo.
    Gaster LM, Blaney FE, Davies S, Duckworth DM, Ham P, Jenkins S, Jennings AJ, Joiner GF, King FD, Mulholland KR, Wyman PA, Hagan JJ, Hatcher J, Jones BJ, Middlemiss DN, Price GW, Riley G, Roberts C, Routledge C, Selkirk J, Slade PD.
    J Med Chem; 1998 Apr 09; 41(8):1218-35. PubMed ID: 9548813
    [Abstract] [Full Text] [Related]

  • 60. SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties.
    Forbes IT, Douglas S, Gribble AD, Ife RJ, Lightfoot AP, Garner AE, Riley GJ, Jeffrey P, Stevens AJ, Stean TO, Thomas DR.
    Bioorg Med Chem Lett; 2002 Nov 18; 12(22):3341-4. PubMed ID: 12392747
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.